A5102792471- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Cardiac, Anesthesia and Surgical Outcomes
- Central Venous Catheters and Hemodialysis
- Diagnosis and Treatment of Venous Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- Hemodynamic Monitoring and Therapy
- Cancer Treatment and Pharmacology
- Sepsis Diagnosis and Treatment
- Blood Coagulation and Thrombosis Mechanisms
- Vascular Procedures and Complications
- Case Reports on Hematomas
- Peripheral Artery Disease Management
- Chemotherapy-induced cardiotoxicity and mitigation
- Organ Donation and Transplantation
- COVID-19 Clinical Research Studies
- Chemotherapy-related skin toxicity
- Blood transfusion and management
- COVID-19 and healthcare impacts
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Organ Transplantation Techniques and Outcomes
- Shoulder Injury and Treatment
- Bariatric Surgery and Outcomes
Universidad de Granada
2009-2023
Hospital Universitario Virgen de las Nieves
2003-2023
Lithuanian University of Health Sciences
2017-2019
American Society of Clinical Oncology
2015
Fred Hutch Cancer Center
2015
Cancer Research Center
2015
University of British Columbia
2013
Venous thromboembolism (VTE) is often asymptomatic, mis-diagnosed, and unrecognized at death, there a lack of routine postmortem examinations. These factors are thought to result in marked underestimates ofVTE incidence. The objective our study was estimate the total burden VTE within European Union (EU) per annum. An epidemiological model constructed number community- hospital-acquired incidents recurrent cases (attack rate) nonfatal VTE-related deaths, as well incident prevalent...
To provide current recommendations about the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer.PubMed Cochrane Library were searched for randomized controlled trials, systematic reviews, meta-analyses, clinical practice guidelines from November 2012 through July 2014. An update committee reviewed identified abstracts.Of 53 publications reviewed, none prompted a change 2013 recommendations.Most hospitalized active cancer require thromboprophylaxis throughout...
Summary Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at death, there a lack of routine postmortem examinations. These factors are thought to result in marked underestimates ofVTE incidence. The objective our study was estimate the total burden VTE within European Union (EU) per annum. An epidemiological model constructed number community- hospital-acquired incidents recurrent cases (attack rate) nonfatal VTE-related deaths, as well incident prevalent...
Summary Hospitalized patients with acute medical conditions are at significant risk of venous thromboembolism (VTE): approximately 10–30% general may develop deep-vein thrombosis or pulmonary embolism, and the latter is a leading contributor to deaths in hospital. Despite consensus-group recommendations that at-risk should receive thromboprophylaxis, there currently no consensus as which risk, many not appropriate thromboprophylaxis. This paper reviews evidence for VTE associated different...
Summary Venous thromboembolism (VTE) risk persists for several weeks following high-risk orthopaedic surgery (HROS). The ETHOS registry evaluated post-operative VTE prophylaxis prescribed, and actual received, compared with the 2004 American College of Chest Physicians (ACCP) guidelines in HROS patients. We performed a subanalysis to assess patient compliance ACCP-adherent after discharge factors predicting poor compliance. Consecutive patients undergoing hip fracture surgery, total...
Summary Real-life data on post-discharge venous thromboembolism (VTE) prophylaxis practices and treatments are lacking. We assessed post-operative VTE prescribed received in a prospective registry, compared with the 2004 American College of Chest Physicians (ACCP) guidelines high-risk orthopaedic surgery patients. Consecutive patients undergoing total hip arthroplasty (THA), fracture (HFS), or knee (KA) were enrolled at discharge from 161 centres 17 European countries if they had in-hospital...
Background Atrial fibrillation (AF) may exist before or occur early in the course of pulmonary embolism (PE). We determined PE outcomes based on presence and timing AF. Methods Results Using data from a multicenter registry, we identified 3 groups: (1) those with preexisting AF, (2) patients new AF within 2 days acute (incident AF), (3) without assessed 90-day 1-year risk mortality stroke compared (reference group). Among 16 497 PE, 792 had These increased odds all-cause (odds ratio [OR],...